TNFRSF1A and Alzheimer disease: Lastly, a recent study demonstrated in AD mouse models that abrogation of TNFR1 results in decreased brain inflammation and in an improvement of amyloidosis and blood–brain barrier integrity (Steeland et al., 2018).